January 30, 2019
Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
Read More
January 30, 2019
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Read More
January 30, 2019
Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer
Read More
January 30, 2019
Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
Read More
January 30, 2019
A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).
Read More
January 30, 2019
A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).
Read More
January 30, 2019
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Read More
January 30, 2019
Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment
Read More
January 30, 2019
Trial to Assess Safety and Efficacy of Lenvatinib in Combination With Everolimus in Participants With Renal Cell Carcinoma
Read More
January 30, 2019
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®
Read More
January 30, 2019
A Study to Assess the Immunogenicity and Safety of GSK Biologicals’ Infanrix® -IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
Read More
January 30, 2019
A Study to Assess the Immunogenicity and Safety of GSK Biologicals’ Infanrix® -IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
Read More
Load More
X